Limitations include that although all GLP-1 agonist users had a record for obesity without diabetes, whether GLP-1 agonists were all used for weight loss is uncertain
Degn KB, Brock B, Juhl CB, et al
Nota AIFA100 L'accesso gratuito tramite il Servizio Sanitario Nazionale riservato esclusivamente ai pazienti con diagnosi di diabete di tipo 2 che rispettano i parametri prescrittivi della Nota AIFA 100
Optimizing GLP-1 dose, adding resistance training, addressing sleep and protein intake, and re evaluating diet are all evidence based
Phentermine and semaglutide (Zepbound) target weight loss through different mechanisms, but combining them carries cardiovascular risks that most clinicians avoid
First Month Membership Monthly Membership Wegovy * * Off-label divided dosing Zepbound * * Off-label divided dosing Note: weight loss treatment is available exclusively to active members